Angiographic Changes after Bevacizumab

Saved in:
Bibliographic Details
Published inOphthalmology (Rochester, Minn.) Vol. 116; no. 11; pp. 2263 - 2263.e1
Main Authors Ikuno, Yasushi, MD, Soga, Kaori, MD, Wakabayashi, Taku, MD, Gomi, Fumi, MD
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.11.2009
Subjects
Angiogenesis Inhibitors - administration & dosage
Angiogenesis Inhibitors - adverse effects
Antibodies, Monoclonal - administration & dosage
Antibodies, Monoclonal - adverse effects
Antibodies, Monoclonal, Humanized
Bevacizumab
Choroid Diseases - chemically induced
Choroid Diseases - diagnosis
Choroidal Neovascularization - drug therapy
Choroidal Neovascularization - etiology
Coloring Agents
Female
Fluorescein Angiography - drug effects
Humans
Indocyanine Green
Injections
Male
Middle Aged
Myopia, Degenerative - complications
Ophthalmology
Retinal Pigment Epithelium - drug effects
Retinal Pigment Epithelium - pathology
Vascular Endothelial Growth Factor A - antagonists & inhibitors
Visual Acuity
Vitreous Body
Online AccessGet full text

Cover

More Information
ISSN:0161-6420
1549-4713
DOI:10.1016/j.ophtha.2009.08.004